Showing results 1 to 20 of 22
next >
| Issue Date | Title | Author(s) | Citation |
| 2016 | Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma | Fulham, Michael; Trotman, Judith; Berkahn, Leanne; Carella, Angelo; D'Amore, Francesco; Enblad, Gunilla; et al, Various; Federico, Massimo; Fossa, Alexander; Franceschetto, Antonella; Johnson, Peter; Kirkwood, Amy A.; Schl Information Technologies; Concord Clinical School: Medicine | Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma, The New England Journal of Medicine, vol.374, 25, 2016,pp 2419-2429 |
| 2016 | Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: A pooled analysis of three multicenter studies | Trotman, Judith; Boussetta, Sami; Casasnovas, Rene Olivier; Chartier, Loic; Cottereau, Anne Segolene; Dupuis, Jehan; et al, Various; Grassi, Ilaria; Haioun, Corinne; Meignan, Michel; Versari, Annibale; Concord Clinical School: Medicine | Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: A pooled analysis of three multicenter studies, Journal of Clinical Oncology, vol.34, 30, 2016,pp 3618-3626 |
| 2017 | Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial | Trotman, Judith; Dummer, R; et al, Various; Horwitz, Steven; Kim, Youn H; Prince, H. Miles; Quaglino, Pietro; Sanches, Jose; Scarisbrick, J; Wolter, Pascal; Zinzani, Pier Luigi; Concord Clinical School: Medicine | Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial, The Lancet, vol.390, 10094, 2017,pp 555-566 |
| 2015 | Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with Diffuse Large B Cell Lymphoma: an Australian retrospective analysis | Millar, A; Trotman, Judith; Caudron, A; Cochrane, T; Ellis, Mary R; Fletcher, Julie; Mollee, Peter N; Webster, Bradley; Concord Clinical School: Medicine; Concord Clinical School: Medicine | Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with Diffuse Large B Cell Lymphoma: an Australian retrospective analysis, Internal Medicine Journal, vol.45, 11, 2015,pp 1147-1153 |
| 2017 | Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14 | Trotman, Judith; Butcher, Belinda; Cull, Gavin; et al, Various; Fay, Keith; Gandhi, Maher K.; Gill, Devinder; Hertzberg, Mark; Ho, Shir-Jing; Johnston, Amanda; Taper, John; Concord Clinical School: Medicine | Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14, Haematologica, vol.102, 2, 2017,pp 356-363 |
| 2017 | Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practice | Cunningham, Ilona; Curnow, Jennifer; Estell, Jane; Foo, Kerwyn; Gasiorowski, Robin Edward; Lee, Kenneth; Trotman, Judith; Archer, K; Bianchi, Alessandra; Fletcher, Julie; Kwan, Yiu Lam; Siedlecka, E; Trinh, Jimmy; Verner, Emma; Wignall, L; Concord Clinical School: Medicine; Clinical Schools; Concord Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine | Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practice, Internal Medicine Journal, vol.47, 5, 2017,pp 542-548 |
| 2016 | High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation | Earl, John; Gurney, Howard; Joshua, Douglas; Kerridge, Ian; McLachlan, Andrew; Shaw, Peter; Trotman, Judith; Kwan, Yiu Lam; Nath, Christa; Nivison-Smith, Ian; Presgrave, Peter; Tiley, Campbell; Zeng, Lihua; Childrens Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Ctr for Values Ethics & Law in Med; Pharmacy; Childrens Hospital Westmead: Paediatrics & Child Health; Concord Clinical School: Medicine | High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation, British Journal of Clinical Pharmacology, vol.82, 1, 2016,pp 149-159 |
| 2018 | Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study | Trotman, Judith; Balasubramanian, Sriram; Caballero, Dolores; Cheson, Bruce D; Damle, Rajendra; Deshpande, Sanjay; Fowler, Nathan; Gartenberg, Gary; Gopal, Ajay; Hess, Georg; Hou, Jing-Zhou; Jurczak, Wojciech; Lill, Michael; Martin, Peter; Morton, James; Radford, John; Salles, Gilles; Schaffer, Michael; Schuster, Stephen; Spencer, Andrew; Vermeulen, Jessica; Vitolo, Umberto; Wang, Shean-Sheng; Yacoub, Abdulraheem; Concord Clinical School: Medicine | Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study, Journal of Clinical Oncology, vol.36, 23, 2018,pp 2405-2412 |
| 2017 | Ibrutinib for patients with rituximab-refractory Waldenstrom's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial | Trotman, Judith; Dimopoulos, Meletios Athanassios; et al, Various; Heffner, L; Ma, Shuo; Macdonald, D; Matous, J; Oriol, Albert; Tam, Constantine; Tedeschi, A; Tournilhac, O; Concord Clinical School: Medicine | Ibrutinib for patients with rituximab-refractory Waldenstrom's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial, The Lancet Oncology, vol.18, 2, 2017,pp 241-250 |
| 2018 | Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety | Trotman, Judith; Barbui, Anna Maria; Burciu, Alis; Canales, Miguel; Cannell, Paul; Collins, Graham; Durig, Jan; Fingerle-Rowson, Gunter; Forstpointner, Roswitha; Herold, Michael; Hertzberg, Mark; Hiddemann, Wolfgang; Klanova, Magdalena; Marcus, Robert; Nielsen, Tina; Radford, John; Seymour, John Francis; Tobinai, Kensei; Wolbers, Marcel; Concord Clinical School: Medicine | Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety, Journal of Clinical Oncology, vol.36, 23, 2018,pp 2395-2406 |
| 2017 | Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone | Trotman, Judith; Casasnovas, Rene Olivier; et al, Various; Fruchart, Christophe; Gomes da Silva, Maria; Grosicka, Anida; Haioun, Corinne; Lazarovici, Julien; Morschhauser, Franck; Thieblemont, Catherine; Tilly, H; Concord Clinical School: Medicine | Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone, Journal of Clinical Oncology, vol.35, 22, 2017,pp 2473-2481 |
| 2016 | PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study | Fulham, Michael; Trotman, Judith; Almquist, Helen; Barrington, Sally F; Brun, Eva; et al, Various; Franceschetto, Antonella; Hjorthaug, Karin; Kirkwood, Amy A.; Pike, Lucy C.; Roberts, Thomas H.; Viney, Zaid; Information Technologies; Concord Clinical School: Medicine | PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study, Blood, vol.127, 12, 2016,pp 1531-1538 |
| 2014 | PET/CT assessment in follicular lymphoma using standardized criteria: Central review in the PRIMA study | Fulham, Michael; Trotman, Judith; Fournier, Marion; Lamy, Thierry; Meignan, Michel; Ricard, Fabien; Salles, Gilles; Tychyj-Pinel, Christelle; Vera, Pierre; Central Clinical School: Medicine; Concord Clinical School: Medicine | PET/CT assessment in follicular lymphoma using standardized criteria: Central review in the PRIMA study, European Journal of Nuclear Medicine and Molecular Imaging, vol.41, 3, 2014,pp 408-415 |
| 2018 | Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia | Trotman, Judith; Buske, C; Dimopoulos, Meletios A; Garcia-Sanz, Ramon; Graef, T; Herbaux, Charles; Kastritis, Efstathios; Leblond, Veronique; Li, J; Macdonald, David; Mahe, Beatrice; Matous, J; Orsucci, Lorella; Palomba, M Lia; Salman, Zeena; Shustik, C; Tam, C; Tedeschi, A; Treon, S; Concord Clinical School: Medicine | Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia, New England Journal of Medicine, vol.378, 25, 2018,pp 2399-2410 |
| 2010 | Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy | Gurney, Howard; Joshua, Douglas; Kerridge, Ian; McLachlan, Andrew; Shaw, Peter; Trotman, Judith; Duffull, Stephen B.; Earl, John W; Hegarty, Gareth; Kwan, Yiu Lam; Nath, Christa E.; Presgrave, Peter; Tiley, Campbell; Zeng, Lihua; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Ctr for Values Ethics & Law in Med; Pharmacy; Children's Hospital Westmead: Paediatrics & Child Health; Concord Clinical School: Medicine | Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy, British Journal of Clinical Pharmacology, vol.69, 5,pp 484-497 |
| 2011 | Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants. | Estell, Jane; Fulham, Michael; Trotman, Judith; Decaudin, Didier; et al, various; Fabiani, Bettina; Forsyth, Cecily; Fournier, Marion; Gabarre, Jean; Gyan, Emmanuel; Janíkova, Andrea; Lamy, Thierry; Salles, Bruno; Seymour, John Francis; Shpilberg, Ofer; Sonet, Anne; Tilly, Hervé; Concord Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine | Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants., Journal of Clinical Oncology, vol.29, 23, 2011,pp 3194-3200 |
| 2017 | Report of the 6th International Workshop on PET in lymphoma | Trotman, Judith; Barrington, Sally F; Bodet-Milin, C; Coronado, M; Cottereau, Anne Segolene; Duhrsen, Ulrich; et al, Various; Kim, Wong Seog; Lopci, E; Nanni, C; Pro, Barbara; Concord Clinical School: Medicine | Report of the 6th International Workshop on PET in lymphoma, Leukemia & Lymphoma, vol.58, 10, 2017,pp 2298-2303 |
| 2014 | Rising cost of anticancer drugs in Australia | Karikios, Deme; Mann, Kristy; Salkeld, Glenn; Schofield, Deborah; Stockler, Martin; Trotman, Judith; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; Pharmacy; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: Medicine | Rising cost of anticancer drugs in Australia, Internal Medicine Journal, vol.44, 5, 2014,pp 458-463 |
| 2014 | Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group | Trotman, Judith; Barrington, Sally F; Biggi, Alberto; Cheson, Bruce D; Fisher, Richard I; Hicks, Rodney J.; Hoekstra, Otto S.; Hustinx, Roland; Hutchings, Martin; Kostakoglu, Lale; Müeller, Stefan P.; Meignan, Michel; Mikhaeel, George N; O’Doherty, Michael J; Schwartz, Lawrence H; Zucca, Emanuele; Concord Clinical School: Medicine | Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group, Journal of Clinical Oncology, vol.32, 27, 2014,pp 3048-3058 |
| 2008 | Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function | Chung, T; Cunningham, Ilona; Kritharides, Leonard; Lim, W C; Sy, R; Trotman, Judith; Concord Clinical School: ANZAC Research Institute; Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine | Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function, Heart, vol.94, 7, 2008,pp 911-918 |